Xiaowen Ge

542 total citations
22 papers, 385 citations indexed

About

Xiaowen Ge is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Xiaowen Ge has authored 22 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Xiaowen Ge's work include Complement system in diseases (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and HER2/EGFR in Cancer Research (5 papers). Xiaowen Ge is often cited by papers focused on Complement system in diseases (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and HER2/EGFR in Cancer Research (5 papers). Xiaowen Ge collaborates with scholars based in China, United States and United Kingdom. Xiaowen Ge's co-authors include Weiguo Hu, Xuebin Qin, José A. Halperin, Tao You, Jennifer R. Brown, Yingyong Hou, Ting Xu, Jingnan Shen, Michael Chorev and Gongxiong Wu and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Xiaowen Ge

21 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaowen Ge China 11 161 86 82 81 74 22 385
Yoshitaka Kinoshita Japan 8 130 0.8× 78 0.9× 76 0.9× 130 1.6× 37 0.5× 33 425
David Soler United States 12 249 1.5× 94 1.1× 42 0.5× 134 1.7× 36 0.5× 26 505
Caterina Baldi Italy 10 100 0.6× 42 0.5× 27 0.3× 92 1.1× 48 0.6× 52 423
Yuxing Shan China 9 246 1.5× 86 1.0× 66 0.8× 93 1.1× 16 0.2× 11 478
Mei Liu China 12 103 0.6× 69 0.8× 55 0.7× 116 1.4× 28 0.4× 31 387
Xiangcong Zhao China 12 186 1.2× 53 0.6× 18 0.2× 89 1.1× 25 0.3× 37 413
Yeong-Wook Song South Korea 8 89 0.6× 43 0.5× 19 0.2× 80 1.0× 52 0.7× 13 382
Montserrat Alvarez Switzerland 11 275 1.7× 67 0.8× 27 0.3× 83 1.0× 19 0.3× 14 508
Barbara Reich Germany 7 214 1.3× 35 0.4× 21 0.3× 99 1.2× 46 0.6× 9 454
George Mo United States 8 82 0.5× 165 1.9× 13 0.2× 89 1.1× 66 0.9× 19 345

Countries citing papers authored by Xiaowen Ge

Since Specialization
Citations

This map shows the geographic impact of Xiaowen Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowen Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowen Ge more than expected).

Fields of papers citing papers by Xiaowen Ge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaowen Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowen Ge. The network helps show where Xiaowen Ge may publish in the future.

Co-authorship network of co-authors of Xiaowen Ge

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaowen Ge. A scholar is included among the top collaborators of Xiaowen Ge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaowen Ge. Xiaowen Ge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ge, Xiaowen, Xinxin Guo, Ling Li, et al.. (2023). Complement and complement regulatory proteins are upregulated in lungs of COVID-19 patients. Pathology - Research and Practice. 247. 154519–154519. 8 indexed citations
2.
Ge, Xiaowen, et al.. (2022). Communication-Censored Distributed Learning for Stochastic Configuration Networks. 12(2). 21–37. 1 indexed citations
3.
Wang, Xin, Xiaowen Ge, Hai Wang, et al.. (2021). SOX2 amplification and chromosome 3 gain significantly impact prognosis in esophageal squamous cell carcinoma. Annals of Translational Medicine. 9(4). 321–321. 6 indexed citations
4.
Ge, Xiaowen, Yiqun Du, Jianfeng Chen, et al.. (2021). Herbal NF-κB Inhibitors Sensitize Rituximab-Resistant B Lymphoma Cells to Complement-Mediated Cytolysis. Frontiers in Oncology. 11. 751904–751904. 3 indexed citations
5.
Xu, Chen, Yalan Liu, Dongxian Jiang, et al.. (2019). Late stage gastric cancer patients with extra gained HER2 positivity by dual block assessment may not show compromised efficacy to trastuzumab treatment. Aging. 11(22). 10052–10060. 4 indexed citations
6.
Ge, Xiaowen, Jianfeng Chen, Ling Li, et al.. (2018). Midostaurin potentiates rituximab antitumor activity in Burkitt’s lymphoma by inducing apoptosis. Cell Death and Disease. 10(1). 8–8. 12 indexed citations
7.
Ge, Xiaowen, Na Zhu, Haiying Zeng, et al.. (2018). A case report of nodal CD4-positive T-cell lymphoproliferative disorder with an indolent course. Medicine. 97(10). e0099–e0099.
8.
Ge, Xiaowen, Chen Xu, Yalan Liu, et al.. (2018). Complement activation in the arteries of patients with severe atherosclerosis.. PubMed. 11(1). 1–9. 10 indexed citations
9.
10.
Xu, Chen, Yalan Liu, Dongxian Jiang, et al.. (2017). Poor efficacy response to trastuzumab therapy in advanced gastric cancer with homogeneous HER2 positive and non-intestinal type. Oncotarget. 8(20). 33185–33196. 9 indexed citations
11.
Xu, Chen, Yalan Liu, Xiaowen Ge, et al.. (2017). Tumor containing fragment number influences immunohistochemistry positive rate of HER2 in biopsy specimens of gastric cancer. Diagnostic Pathology. 12(1). 41–41. 9 indexed citations
12.
Liu, Fengming, Rupam Sahoo, Xiaowen Ge, et al.. (2016). Deficiency of the complement regulatory protein CD59 accelerates the development of diabetes-induced atherosclerosis in mice. Journal of Diabetes and its Complications. 31(2). 311–317. 17 indexed citations
13.
Ge, Xiaowen, Haiying Zeng, Akesu Sujie, et al.. (2015). Hepatocellular carcinoma with concomitant hepatic angiomyolipoma and cavernous hemangioma in one patient. World Journal of Gastroenterology. 21(11). 3414–3419. 6 indexed citations
14.
Ge, Xiaowen, Hai Wang, Haiying Zeng, et al.. (2015). Clinical significance of assessing Her2/neu expression in gastric cancer with dual tumor tissue paraffin blocks. Human Pathology. 46(6). 850–857. 22 indexed citations
15.
Wu, Lin, Fengming Liu, Tao Xu, et al.. (2012). Removal of the Tag from His-tagged ILYd4, a Human CD59 Inhibitor, Significantly Improves its Physical Properties and its Activity. Current Pharmaceutical Design. 18(27). 4187–4196. 11 indexed citations
16.
Ge, Xiaowen, Lin Wu, Weiguo Hu, et al.. (2011). rILYd4, a Human CD59 Inhibitor, Enhances Complement-Dependent Cytotoxicity of Ofatumumab against Rituximab-Resistant B-cell Lymphoma Cells and Chronic Lymphocytic Leukemia. Clinical Cancer Research. 17(21). 6702–6711. 39 indexed citations
17.
Hu, Weiguo, Xiaowen Ge, Tao You, et al.. (2011). Human CD59 Inhibitor Sensitizes Rituximab-Resistant Lymphoma Cells to Complement-Mediated Cytolysis. Cancer Research. 71(6). 2298–2307. 74 indexed citations
18.
You, Tao, Weiguo Hu, Xiaowen Ge, Jingnan Shen, & Xuebin Qin. (2011). Application of a novel inhibitor of human CD59 for the enhancement of complement-dependent cytolysis on cancer cells. Cellular and Molecular Immunology. 8(2). 157–163. 36 indexed citations
19.
Ge, Xiaowen, et al.. (2011). Vascular endothelial growth factor receptor 2 (VEGFR2, Flk‐1/KDR) protects HEK293 cells against CoCl2‐induced hypoxic toxicity. Cell Biochemistry and Function. 30(2). 151–157. 6 indexed citations
20.
Hu, Weiguo, Richard C. Jin, Jinyan Zhang, et al.. (2010). The critical roles of platelet activation and reduced NO bioavailability in fatal pulmonary arterial hypertension in a murine hemolysis model. Blood. 116(9). 1613–1622. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshitaka Kinoshita Breakdown of academic impact, for papers by David Soler Breakdown of academic impact, for papers by Caterina Baldi Breakdown of academic impact, for papers by Yuxing Shan Breakdown of academic impact, for papers by Mei Liu Breakdown of academic impact, for papers by Xiangcong Zhao Breakdown of academic impact, for papers by Yeong-Wook Song Breakdown of academic impact, for papers by Montserrat Alvarez Breakdown of academic impact, for papers by Barbara Reich Breakdown of academic impact, for papers by George Mo
Rankless by CCL
2026